Blueprint Medicine Stock Price
Listing Websites about Blueprint Medicine Stock Price
BPMC Stock Price Blueprint Medicines Corp. Stock Quote
(8 days ago) Blueprint Medicines started at overweight with $112 stock price target at Morgan Stanley Apr. 3, 2019 at 9:44 a.m. ET by Tomi Kilgore Cancer stocks heat up after third big merger in the past month
Blueprint Medicines Corporation Common Stock (BPMC) …
(Just Now) Blueprint Medicines Corporation Common Stock (BPMC) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Blueprint Medicines Corporation (BPMC) Stock Price …
(6 days ago) A high-level overview of Blueprint Medicines Corporation (BPMC) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Stock information Blueprint Medicines Corp.
(3 days ago) Stock information. SEC filings. Corporate governance. Corporate responsibility. Annual meeting. Analyst coverage. Investor contact Kristin Hodous Senior Manager, Investor Relations [email protected] 617.714.6674 Media contact Andrew Law Director, Corporate Communications [email protected] 617.844.8205.
Blueprint Medicines Corp - Company Profile and News
(9 days ago) Company profile page for Blueprint Medicines Corp including stock price, company news, press releases, executives, board members, and contact information
(5 days ago) Blueprint Medicines and Zai Lab Announce Strategic Collaboration and License Agreement for BLU-945 and BLU-701 in Greater China Nov 05, 2021 Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) More News Events and presentations Oct 28, 2021 Q3 2021 Blueprint Medicines Corp Conference Call Sept 09, 2021
BPMC - Stock quote for BLUEPRINT MEDICINES CORPORATION
(4 days ago) Blueprint Medicines Corp (BPMC): Price Now Near $94.75; Daily Chart Shows An Uptrend on 20 Day Basis. ETF Daily News 8/18/2021.
Blueprint Medicines (BPMC) Stock Price, News & Info The
(9 days ago) Blueprint Medicines Tumbles 20.8% on Phase 3 Study Failure. Maxx Chatsko Apr 28, 2020. A closely watched drug candidate didn't meet the primary endpoint of a late-stage trial, which creates a
Blueprint Medicines Corporation (BPMC) Stock Price, Quote
(8 days ago) Blueprint Medicines (BPMC) Reports Q3 Loss, Misses Revenue Estimates. Blueprint Medicines (BPMC) delivered earnings and revenue surprises of -18.34% and -39.72%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock? 3 weeks ago - Zacks Investment Research.
Blueprint Medicines Company Profile: Stock Performance
(7 days ago) Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT Exon 17 mutants and PDGFRa D842V, abnormally
Blueprint Medicines Stock Forecast: up to 127.608 USD
(3 days ago) Blueprint Medicines Corp () Stock Market info Recommendations: Buy or sell Blueprint Medicines stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Blueprint Medicines share forecasts, stock quote and buy / sell signals below.According to present data Blueprint Medicines's BPMC shares and potentially its market environment have been in a bullish cycle in
Blueprint Medicines - BPMC - Stock Price Today - Zacks
(2 days ago) View Blueprint Medicines BPMC investment & stock information. Get the latest Blueprint Medicines BPMC detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
Blueprint Medicines Price Target, Predictions & Analyst
(9 days ago) According to the issued ratings of 11 analysts in the last year, the consensus rating for Blueprint Medicines stock is Buy based on the current 4 hold ratings, 6 buy ratings and 1 strong buy rating for BPMC. The average twelve-month price target for Blueprint Medicines is $122.30 with a high price target of $152.00 and a low price target of $95.00.
Is Blueprint Medicines a Good Biotech Stock to Buy Now
(3 days ago) Blueprint's drug helped eight patients out 114 achieve complete remission, while Retvmo led to complete remission for just two out of 144 patients treated. Stock Advisor list price is …
Blueprint Medicines - Stock Price History BPMC MacroTrends
(6 days ago) Historical daily share price chart and data for Blueprint Medicines since 2021 adjusted for splits. The latest closing stock price for Blueprint Medicines as of November 03, 2021 is 112.06.. The all-time high Blueprint Medicines stock closing price was 124.48 on December 23, 2020.; The Blueprint Medicines 52-week high stock price is 125.61, which is 12.1% above the current share price.
Blueprint Medicines Stock Quote. BPMC - Stock Price, News
(7 days ago) Blueprint Medicines (BPMC) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.
Blueprint Medicines Corp Stock Forecast & Predictions: 1Y
(6 days ago) On average, Wall Street analysts predict that . Blueprint Medicines Corp's share price could stay at $116.63 by Nov 10, 2022. The average Blueprint Medicines Corp stock price prediction forecasts a potential downside of N/A from the current BPMC share price of $108.92.
Pipeline Blueprint Medicines
(4 days ago) 1 Unresectable or metastatic disease.; 2 CStone Pharmaceuticals has exclusive rights to develop and commercialize avapritinib, pralsetinib and fisogatinib in Mainland China, Hong Kong, Macau and Taiwan.; 3 Approved in the U.S. for the treatment of adults with unresectable or metastatic GIST harboring a PDGFRA exon 18 mutation, including PDGFRA D842V mutations.
Blueprint Medicines (BPMC) Misses on Q3 Earnings
(6 days ago) Blueprint Medicines (BPMC) misses earnings and revenue estimates for the third quarter of 2021. Yet, the stock price surges as the company provides encouraging pipeline updates.
BPMC - Blueprint Medicines Corp Stock Price - Barchart.com
(3 days ago) CAMBRIDGE, Mass. (AP) _ Blueprint Medicines Corp. (BPMC) on Thursday reported a third-quarter loss of $117.2 million, after reporting a profit in the same period a year earlier. Deciphera's (DCPH) Qinlock is approved for treating advanced gastrointestinal stromal tumors. The drug has seen solid uptake since its launch.
BPMC Stock News BLUEPRINT MEDICINES Stock Price Today
(3 days ago) BPMC: Get the latest Blueprint Medicines stock price and detailed information including BPMC news, historical charts and realtime prices.
BPMC Stock Price & Charts Blueprint Medicines
(4 days ago) Analyst Actions: Wedbush Adjusts Price Target on Blueprint Medicines to $136 From $119 on BLU-263, -701, -945 Potential; Outperform Rating Kept. 04/13 06:39. SA Breaking News. Blueprint Medicines reports data from systemic mastocytosis program at AACR 2021. 04/12 05:24.
Historical BPMC stock prices (quote) - Blueprint Medicines
(9 days ago) Range Low Price High Price Comment; 30 days: $99.30: $117.86: Friday, 19th Nov 2021 BPMC stock ended at $108.92.This is 1.33% less than the trading day before Thursday, 18th Nov 2021. During the day the stock fluctuated 2.20% from a day low at $108.61 to a day high of $111.00.: 90 days
BPMC - Blueprint Medicines Corp Stock Options Prices
(1 days ago) Stocks Option prices for Blueprint Medicines Corp with option quotes and option chains. (IV) is the estimated volatility of the underlying stock over the period of the option. IV can help traders determine if options are fairly valued, undervalued, or overvalued. It can therefore help traders make decisions about option pricing, and whether
Blueprint Medicines Corp., BPMC Quick Chart - (NAS) BPMC
(9 days ago) News for Blueprint Medicines Corp. Thursday, September 30, 2021. 07:07 AM ET. Blueprint Medicines coverage resumed at Stifel with hold stock rating and $105 target price MarketWatch. Thursday, December 03, 2020
Blueprint Medicines Announces Inducement Grants Under
(6 days ago) The options have an exercise price of $112.82 per share, which is equal to the closing price of Blueprint Medicines' common stock on November 1, 2021. Each option will vest as to 25% of the shares underlying such option on the first anniversary of the grant date and as to an additional 1/48th of the shares underlying the option monthly
Blueprint Medicines Announces Pricing of Public Offering
(8 days ago) In addition, Blueprint Medicines has granted the underwriters a 30-day option to purchase up to an additional 608,108 shares of its common stock at …
Should You Buy Blueprint Medicines Corp (BPMC) Stock on
(4 days ago) Blueprint Medicines Corp (BPMC) stock has risen 1.56% while the S&P 500 has fallen -0.11% as of 11:16 AM on Thursday, Jun 17. BPMC is higher by $1.34 from the previous closing price of $85.56 on volume of 432,836 shares.
Is it Time to Dump Blueprint Medicines Corp (BPMC) Stock
(Just Now) Blueprint Medicines Corp (BPMC) stock is trading at $101.83 as of 2:45 PM on Tuesday, Oct 19, an increase of $2.61, or 2.63% from the previous closing price of $99.22. The stock has traded between $98.56 and $102.16 so far today. Volume today is …
Blueprint, eyeing an independent future, gets $775M in new
(5 days ago) Through the deal — the second between the two companies since 2016 — Roche will also buy $100 million in Blueprint shares at $96.57 apiece, a roughly 26% premium to the stock's Monday closing price. Blueprint could receive another $927 million in conditional payments tied to development to pralsetinib as well as to a second-generation RET
Blueprint Medicines Market Cap 2014-2021 BPMC MacroTrends
(7 days ago) Blueprint Medicines market cap history and chart from 2014 to 2021. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.
Blueprint Medicines Stock Quote. BPMC - Stock Price, News
(8 days ago) Blueprint Medicines (BPMC) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. 20/11/2021 13:54:31 1-888-992-3836 Free
Blueprint Medicines (BPMC) Reports Q3 Loss, Misses Revenue
(8 days ago) Blueprint Medicines (BPMC) came out with a quarterly loss of $2 per share versus the Zacks Consensus Estimate of a loss of $1.69. This compares to earnings of $11.16 per share a …
Overview Blueprint Medicines Corp.
(4 days ago) Blueprint Medicines and Zai Lab Announce Strategic Collaboration and License Agreement for BLU-945 and BLU-701 in Greater China Nov 05, 2021 Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BPMC Stock Forecast and Price Target (Blueprint Medicines
(6 days ago) Close price at the end of the last trading day (Wednesday, 10th Nov 2021) of the BPMC stock was $114.26. This is 0.6% less than the trading day before Tuesday, 9th Nov 2021. During the day the stock fluctuated 3.73% from a day low at $113.62 to a day high of $117.86.
Blueprint Education Announces the Acquisition of Rosh
(9 days ago) Nov. 11, 2021, 03:32 PM. LOS ANGELES, Nov. 11, 2021 /PRNewswire/ -- Blueprint Education ("Blueprint" or the "Company") has completed the acquisition of Rosh Review ("Rosh"), an industry-leading
BPMC Stock Quote Price Chart Volume Chart Blueprint
(2 days ago) Blueprint Medicines trades on the NASDAQ stock market under the symbol BPMC. What is Blueprint Medicines stock price doing today? As of November 5, 2021, BPMC stock price climbed to $114.50 with 479,728 million shares trading.
Blueprint Medicines Co. (NASDAQ:BPMC) Short Interest Down
(6 days ago) As a group, equities analysts anticipate that Blueprint Medicines will post -6.31 EPS for the current fiscal year. In related news, insider L. Becker Hewes sold 729 shares of the firm's stock in a transaction on Monday, November 15th. The stock was sold at an average price of $115.49, for a total transaction of $84,192.21.
Blueprint Medicines Corp (BPMC) Quote - XNAS Morningstar
(Just Now) Quote Stock Analysis News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating Blueprint Medicines Corp is a biopharmaceutical company. Its drug candidates
Editas Medicine (NasdaqGS:EDIT) - Share price, News
(1 days ago) Price target increased to US$54.77. Up from US$50.75, the current price target is an average from 13 analysts. New target price is 6.7% below last closing price of …